Publications

5674 Results

Patients enrolled in clinical trials with Medicaid or no insurance have reduced overall survival benefits from new interventions

Authors
JM Unger;CD Blanke;M LeBlanc;W Barlow;DL Hershman
Journal / Conference
J Clin Oncol 37(suppl 27; abstr 119); ASCO Quality of Care Symposium (Sept 6-7, 2019, San Diego, CA), accepted, oral
Year
2019
Research Committee(s)
Cancer Care Delivery

Socioeconomic deprivation and cancer outcomes in patients treated in clinical trials

Authors
JM Unger;A Moseley;SD Ramsey;RU Osarogiagbon;BE Symington;DL Hershman
Journal / Conference
J Clin Oncol 37 (suppl 27; abstr 162); ASCO Quality of Care Symposium (Sept 6-7, 2019, San Diego, CA), poster
Year
2019
Research Committee(s)
Cancer Care Delivery

Phase II Trial of Cediranib in combination with cisplatin and pemetrexed in chemo naive patients with unresectable malignant pleural mesothelioma (SWOG S0905)

Authors
A Tsao;J Miao;I Wistuba;N Vogelzang;J Heymach;F Fossella;C Lu;M Velasco;B Box-Noriega;J Hueftle;S Gadgeel;M Redman;D Gandara;K Kelly
Journal / Conference
Journal of Clinical Oncology Oct 1;37(28):2537-2547; Aug 6:JCO1900269. doi: 10.1200/JCO.19.00269. [Epub ahead of print]
Year
2019
Research Committee(s)
Lung
PMID
PMID31386610
PMC
PMC7001793
Study Number(s)
S0905

PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) vs. observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143)

Authors
L Harshman;A Puligandla;N Haas;M Allaf;C Drake;D McDermott;S Signoretti;D Cella;RT Gupta;B Shuch;T Choueiri;PN Lara;A Kapoor;D Heng;M Jewett;V Master;M Michaelson;B Leibovich;D Maskens;M Carducci
Journal / Conference
ASCO GU Cancers Symposium (Feb 14-16, 2019, San Francisco, CA), poster
Year
2019
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/EA8143

Allogeneic Hematopoietic Cell Transplantation Compared to Chemotherapy Consolidation in older Acute Myeloid Leukemia (AML) Patients 60-75 Years in First Complete Remission (CR1): An Alliance (A151509), SWOG, ECOG-ACRIN and CIBMTR Study

Authors
C Ustun;J Le-Rademacher;H-L Wang;M Othus;Z Sun;B Major;M-J Zhang;E Storrick;J Lafky;S Chow;K Mrozek;E Attar;C Bloomfield;L Cripe;M Tallman;F Appelbaum;S Nand;R Larson;G Marcucci;G Roboz;GL Uy;RM Stone;A Jatoi;T Shea;M di Lima;J Foran;B Sandmaier;M Litzow;H Erba;A Hurria;D Weisdorf;A Artz
Journal / Conference
Leukemia Nov;33(11):2599-2609
Year
2019
Research Committee(s)
Leukemia
PMID
PMID31073153
PMC
PMC6842042
Study Number(s)
S0432, S0703

E1505: Adjuvant Chemotherapy +/- Bevacizumab for early stage NSCLC: Updated chemotherapy subset analysis

Authors
H Wakelee;SE Dahlberg;S Keller;WJ Tester;DR Gandara;S Graziano;A Adjei;N Leighl;CA Butts;S Aisner;J Rothman;J Patel;MD Sborov;S McDermott;R Perez-Soler;A Traynor;TL Evans;S Ramalingam;JH Schiller
Journal / Conference
WCLC IASCLC Annual Meeting (September 7-10, 2019, Barcelona, Spain), accepted, mini-oral presentation
Year
2019
Research Committee(s)
Lung
Study Number(s)
CTSU/E1505

A Phase III Randomized Study of Nivolumab/Ipilimumab vs Nivolumab for Previously Treated Stage IV Squamous Lung Cancer

Authors
L Bazhenova;M Redman;S Gettinger;F Hirsch;P Mack;L Schwartz;D Gandara;JD Bradley;T Stinchcombe;N Leighl;S Ramalingam;S Tavernier;K Minichiello;K Kelly;V Papadimitrakopoulou;RS Herbst
Journal / Conference
WCLC IASCLC Annual Meeting (September 7-10, 2019, Barcelona, Spain), oral
Year
2019
Research Committee(s)
Lung
Study Number(s)
S1400I

Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Authors
TD Shanafelt;XV Wang;C Hanson;S O'Brien;J Barrietos;J Barrietos;DF Jelinek;D Braggio;J Leis;CC Zhang;SE Coutre;P Barr;A Cashen;A Mato;A Singh;MP Mullane;RF Little;HP Erba;RM Stone;M Litzow;MS Tallman
Journal / Conference
New England Journal of Medicine Aug 1;381(5):432-443
Year
2019
Research Committee(s)
Leukemia
PMID
PMID31365801
PMC
PMC6908306
Study Number(s)
CTSU/E1912

An Anatomic Classification System for Local Recurrence Following Resection of Intermediate and High Risk Non-Metastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Trial

Authors
Z Lee;O Jegede;N Haas;M Pins;E Messing;J Manola;C Wood;C Kane;M Jewett;K Flaherty;J Dutcher;R DiPaola;R Uzzo
Journal / Conference
Journal of Urology Vol. 201, No. 4S, Supplement, abst MP14-18, poster (American Urological Association Annual Meeting,May 3-6, 2019, Chicago, IL)
Year
2019
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/E2805

CALGB 90203 (ALLIANCE): RADICAL PROSTATECTOMY WITH OR WITHOUT NEOADJUVANT CHEMOHORMONAL THERAPY IN MEN WITH CLINICALLY LOCALIZED, HIGH RISK PROSTATE CANCER

Authors
JA Eastham;G Heller;S Halabi;JP Monk;H Beltran;M Gleave;CP Evans;S Clinton;R Szmulewitz;J Coleman;D Hillman;C Watt;O Hahn;M Taplin;E Small;J Mohler;MJ Morris
Journal / Conference
American Urological Association Annual Meeting (May 3-6, 2019, Chicago, IL), poster
Year
2019
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/C90203